Intravenous nutrition source could reduce side effects of chemotherapy
(Carnegie Mellon University) A single dose of an FDA-approved intravenous nutrition source may be able to significantly reduce the toxicity and increase the bioavailability of platinum-based cancer drugs, according to a study by Carnegie Mellon University biologists published in Scientific Reports.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news
More News: Biology | Cancer | Cancer & Oncology | Chemotherapy | Health | International Medicine & Public Health | Nutrition | Parenteral Nutrition | Study | Toxicology